https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Adverse drug reactions included dizziness, fatigue, nausea and vomiting, fever, and hypertension. Risk factors for LTBI in dialysis patients were identified to prioritize LTBI screening and initiate early treatment. The completion rate in dialysis patients were approximately 2 of 3 patients with mild adverse drug reaction, leading to discontinuation of the treatment. Risk factors for LTBI in dialysis patients were identified to prioritize LTBI screening and initiate early treatment. The completion rate in dialysis patients